基本信息
views: 3
Career Trajectory
Bio
No content for now
Research Interests
Papers共 19 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Andreas Maier,Michael Hartung,Mark Abovsky,Klaudia Adamowicz,Gary D. Bader, Sylvie Baier,David B. Blumenthal,Jing Chen,Maria L. Elkjaer, Carlos Garcia-Hernandez,Mohamed Helmy,Markus Hoffmann,Igor Jurisica,Max Kotlyar,Olga Lazareva,Hagai Levi,Markus List,Sebastian Lobentanzer,Joseph Loscalzo,Noel Malod-Dognin,Quirin Manz,Julian Matschinske,Miles Mee,Mhaned Oubounyt,Chiara Pastrello,Alexander R. Pico,Rudolf T. Pillich,Julian M. Poschenrieder,Dexter Pratt,Natasa Przulj,Sepideh Sadegh,Julio Saez-Rodriguez,Suryadipto Sarkar, Gideon Shaked,Ron Shamir,Nico Trummer, Ugur Turhan,Rui-Sheng Wang,Olga Zolotareva,Jan Baumbach
Nucleic acids research (2024)
Fernando Miguel Delgado-Chaves,Sepideh Sadegh, James Skelton, Andreas Maier, Michael Hartung,Elisa Anastasi,David B. Blumenthal,Marisol Salgado-Albarrán, Gihanna Galindez,Olga Lazareva,Anil Wipat, Tim Kacprowski,Jan Baumbach
Streamlining and generalizing network-based drug discovery with NeDRex and DrugstOne (2023)
Network modules as molecular disease definitions for mechanism-based endotyping anddrug repurposing (2022)
Network pharmacology drug repurposing strategy for neurovascular diseases (2022)
A plug-and-play solution to bring network exploration and drug repurposing to biomedical web platforms (2022)
Targeting infectious diseases The CoVex example (2022)
NeDRex - an integrative and interactive network medicine platform for drug repurposing (2022)
Load More
Author Statistics
#Papers: 20
#Citation: 452
H-Index: 7
G-Index: 20
Sociability: 5
Diversity: 0
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn